{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-011630","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.165781+00:00","generated_at":"2026-05-17T19:12:21.496008+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Glucotrack appoints David S. Hirsh, MD as Medical Director, Cardiology","bullets":["Dr. Hirsh, a cardiac electrophysiologist, joins Glucotrack's clinical advisory team for its CBGM program.","He will oversee clinical and educational initiatives supporting the CBGM's intravascular placement approach.","Glucotrack is advancing its CBGM through a long-term OUS early feasibility study and upcoming US pilot study.","CBGM is a long-term implantable system measuring glucose directly from blood, with up to 3-year sensor life."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-011630","json":"https://secwatch.observer/filing/0001493152-25-011630.json","markdown":"https://secwatch.observer/filing/0001493152-25-011630.md","text":"https://secwatch.observer/filing/0001493152-25-011630.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225011630/0001493152-25-011630-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225011630/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:12:21.496008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}